Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Heico
HEI
5
Jefferies Financial
JEF
US OptionsDetailed Quotes
CODX250509C1500
- 0.05
- 0.000.00%
15min DelayTrading Apr 2 14:58 ET
0.00High0.00Low
0.00Open0.05Pre Close0 Volume1 Open Interest1.50Strike Price0.00Turnover2108.44%IV330.56%PremiumMay 9, 2025Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.2983Delta0.7750Gamma7.20Leverage Ratio-0.0493Theta0.0000Rho2.15Eff Leverage0.0001Vega
Co-diagnostics Newsroom
Examining the Future: Co-Diagnostics's Earnings Outlook
Trump wants to impose tariffs on Pharmaceuticals: Pharmaceutical companies are busy stockpiling, and the import volume in the USA surged in March.
① The volume of Pharmaceutical imports in the USA surged in March, as pharmaceutical companies stockpiled products in anticipation of potential tariffs; ② A report released by the US Department of Commerce on Tuesday showed that the total value of Pharmaceutical imports in March exceeded 50 billion USD, equivalent to 20% of the total Pharmaceutical imports for the entire year of 2024.
Earnings Preview: CODX to Report Financial Results Post-market on May 08
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast
This Kohl's Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
Express News | D. Boral Capital Initiates Coverage On Co-Diagnostics With Buy Rating, Announces Price Target of $10
The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.
A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.
Prelude to increased tariffs? The Trump administration has initiated a Section 232 investigation into pharmaceuticals and Semiconductors.
① The USA government disclosed on Monday that it has launched an investigation into the impact of imported Pharmaceuticals and Semiconductors on National Security; ② This is widely seen as a prelude to imposing tariffs on prescription drugs and Semiconductors, and it could further escalate the trade war initiated by the USA.
12 Health Care Stocks Moving In Tuesday's After-Market Session
H.C. Wainwright Maintains Co-diagnostics(CODX.US) With Hold Rating, Cuts Target Price to $1
HC Wainwright & Co. Maintains Neutral on Co-Diagnostics, Lowers Price Target to $1
Co-Diagnostics Analyst Ratings
Co-Diagnostics Faces Financial Challenges and Strategic Adjustments Amid Regulatory Setbacks
Earnings Call Summary | Co-diagnostics(CODX.US) Q4 2024 Earnings Conference
Co-Diagnostics Targets 2025 Clinical Evaluations for TB and HPV Tests in India and South Africa
Co-diagnostics | 10-K: FY2024 Annual Report
Co-Diagnostics FY 2024 GAAP EPS $(1.24) Misses $(1.22) Estimate, Sales $3.900M Miss $4.141M Estimate
Co-Diagnostics 2024 Loss/Shr $1.24 >CODX
Co-Diagnostics 2024 Rev $3.9M >CODX
Press Release: Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
